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Abstract 
The Wnt signalling pathways are ways of signalling 
that transduce signals into cells through cell surface 
receptors; they are three different type of pathways 
and all of these are activated by binding a Wnt-
protein ligand to a Frizzled family receptor. Frizzled 
is a family of G-protein coupled receptor proteins 
that works as receptor in the Wnt signalling pathway; 
when activated, Frizzled works activating the 
Dishevelled protein inside the cell, to transduce the 
signal. Frizzled-5 (FZD5) is part of this family and it 
is encoded by the FZD5 gene (located on the chr2, 
2q33.3). Like all Frizzled members, FZD5 has an 
amino-terminal cysteine-rich domain (CRD) which 
allows the Wnt binding, seven-transmembrane 
domains and a cytoplasmic tail containing the PDZ 
domain binding motif at the carboxy-terminus. 
FZD5 shows an important role in development and 
it seems to be overexpressed in several types of 
cancer. FZD5 preferably binds WNT3A, WNT5A, 
WNT7A and WNT10B, activating both canonical 
and non-canonical pathways. 
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Identity 
Other names: C2orf31, HFZ5, Fz-5, 
DKFZP434E2135, FzE5 
HGNC (Hugo): FZD5 
Location: 2q33.3 
Location (base pair) 
Starts at 207762586 and ends at 207769419 from 
pter (according to hg38-Dec_2013). 
Figure 1:  A) Location of FZD5 gene on chr2. B) Schematic representation of FZD5 gene, with exons 1 and 2. C) Protein 
structure and the subdivision into various domains. 
FZD5 (frizzled class receptor 5) Esposito I 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2019; 23(4) 81 
 
 
Figure 2:  Schematic representation of FZD5 gene. 
 
DNA/RNA 
The FZD5 gene (6978 bp) contains a total of 2 exons 
and the FZD5 transcript is 6708 bp. 
Description 
Genomic size: 6978 bp. Exons count: 2, only one of 
which is coding. This gene has 1 transcript (splice 
variant), 66 orthologues, 12 paralogues. 
Transcription 
1 transcript variant has been found for this gene 
(font. www.ensembl.org). FZD5-201 
ENST00000295417.3: mRNA 6708 bp, protein 585 
aa. 
Protein 
Description 
FZD5 protein, comprised of 585 aa with a mass of 
64 kDa, is part of the frizzled gene family, 7-
transmembrane domain proteins, which includes 10 
members (FZD1 to FZD10). The FZD1-10 are 
bound and activated by the WNT family of 
lipoglycoproteins, inducing a network of signalling 
pathways: the WNT-FZD signalling system has a 
prevalent role in physiology during adulthood and 
dysfunction of this signalling leads to diseases, such 
as cancer and neurological and bone disorders. Wnt 
signals are transduced through at least three different 
pathways, including the canonical Wnt/β-catenin 
pathway, the Wnt/Ca2+ pathway, and the non-
canonical planar cell polarity (PCP). The exclusive 
involvement of FZD5 in one of these three pathways 
is unclear, although some cases have been reported 
that WNT5A activate the canonical pathway in the 
presence of overexpressed FZD5 (He et al., 1997) 
and that WNT7A interacts with FZD5 to activate 
CTNNB1  (β-catenin)/canonical signalling (Carmon 
and Loose, 2008); however other evidences report 
that FZD5 can been associated with non-canonical 
Wnt signalling (Bischoff et al., 2015).  
The secondary structure of FZD5 protein is 
composed by a large domain, the FZ domain, and 
two motifs, the Lys-Thr-X-X-X-Trp motif, and the 
PDZ-binding motif. The FZ domain (from aa 28 to 
aa 150) is an intracellular domain of about 120 amino 
acids, located close to the N-terminal end, first 
identified in the alpha-1 chain of mouse type XVIII 
collagen (Rehn and Pihlajaniemi, 1995).  
The FZ domain, also known as CRD (cysteine rich 
domain) contains 10 conserved cysteines, and its 
crystal structure shows predominance of α -helix 
with disulphide bonds. Its presence is widely 
demonstrated to be involved in Wnt signalling 
(Povelones et al., 2005). The C-terminal cytoplasmic 
Lys-Thr-X-X-X-Trp motif (from aa 525 to aa 530) is 
located two amino acids after the seventh TM and 
frizzled receptors with point mutations into this 
motif lose their capacity to activate Wnt/β-catenin 
signalling (Umbhauer et al., 2000).  
The PDZ domain (from aa 583 to aa 585) is a 
structural domain found in the signalling proteins 
and it plays a role in transport, ion channel signalling 
and transduction system, that typically recognize the 
extreme C-terminal end of the target proteins (Lee 
and Zheng, 2010). 
Expression 
Ishikawa et al. (2001) first isolated and characterized 
this novel mouse frizzled gene Fzd5. Its mRNA was 
expressed in the yolk sac, eyes and lung bud at 9.5 
days post coitum, demonstrating its essential role in 
development.  
In Xenopus embryos, after determining synergistic 
interactions between Wnts and frizzleds, 
misexpression, disruption or depletion of these 
components of Wnt pathway can inhibit the dorsal 
axis formation: these results suggest that the frizzled 
proteins work as receptors for Wnt ligands. To 
confirm that, Ishikawa et al. presents the evidence 
that the homozygous Fzd5 knockout mice are 
embryonically lethal, due to the defects they develop 
in the yolk sac vasculogenesis. Fzd5 is expressed in 
the developing retina in zebrafish, Xenopus Laevis, 
chick and mouse.  
Later, human FZD5 was mapped on chromosome 
2q33.3-q34 (Saitoh et al., 2001) and one of its ligand, 
WNT7A, activate Wnt/β-catenin signalling pathway 
and cell motility/invasion in metastatic melanoma, 
endometrial and ovarian cancer cell lines (Carmon 
and Loose, 2008, Ueno et al., 2013). 
 
 
Figure 3:  Schematic illustration of domains of FZD5 protein. 
FZD5 (frizzled class receptor 5) Esposito I 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2019; 23(4) 82 
 
 
Figure 4:  Visualization of WNT10B-FZD5 interaction in MCF-7 adherent cells (Lazzaroni et al., 2016). 
 
Localisation 
FZD5 is localized at the plasma membrane and it is 
also found at the Golgi apparatus membrane. 
(UniProt FZD5) 
Function 
FZD5 is part of the 7-transmembrane domain 
proteins, receptors for Wnt signalling proteins. 
When the Wnt signalling pathway is activated, FZD 
receptors are internalized in response to their Wnt 
ligands: internalization of FZD5 is induced by 
WNT3A, complexed with LRP6 (Yamamoto et al., 
2006). A recent study (Terabayashi et al., 2009) 
demonstrated that FZD5 is internalized in response 
to WNT3A stimulation via the clathrin-dependent 
pathway to activate downstream signalling 
pathways. Terabayashi et al., found that the 
expression of SCYL2  (CVAK104), a coated vesicle-
associated kinase of 104 kDa which is part of the 
endocytic process, induces intracellular 
accumulation of FZD5 and the latter is internalized 
and degraded by a lysosomal pathway, suggesting a 
model for regulating the turnover of specific 
subclass of FZD receptors. FZD5 protein is believed 
to be the receptor for the WNT5A ligand, in some 
contexts such as the induction of Tissue Factor (TF) 
expression for angiogenesis in monocytes (Arderiu 
et al., 2014), or in the pancreatic cancer context. This 
interaction between WNT5A and FZD5 results in 
activation of the Wnt/β-catenin canonical pathway, 
therefore FZD5 can be considered as a receptor for 
WNT5A (He et al., 1997). Other evidences of 
interaction of FZD5 with WNT5A have been 
provided by Ishikawa et al., investigating the 
presence of WNT5A and WNT10B in the yolk sac 
and inducing the formation of secondary axes in 
Xenopus. The synergy between WNT10B and FDZ5 
has been proved by Lazzaroni et al., (2016), 
confirming an autocrine mechanism for Wnt 
signalling activation in a breast cellular model 
(MCF7). Moreover, FZD5 conjugated with LRP6 
can interact and transduce a WNT7A signal for the 
activation of Wnt/β-catenin canonical signalling 
pathway and for the induction of proliferation in 
endometrial cancer cells (Carmon and Loose, 2008). 
WNT2 is also a FZD5 ligand, and WNT2 deficient 
embryos show placental defects, suggesting their 
role in vascular growth during the developmental 
stage (Ishikawa et al., 2001). FZD5 seems to have 
also an important role in the early stage of the eye 
development; this function may be species-
dependent (Carole et al., 2008). Other findings have 
discovered a FZD5's role in neuronal development 
and polarity. Starting from the evidence that 
WNT3A is essential for neuronal differentiation of 
hNP cells, Bengoa-Vergniory et al., (2016) has 
performed the silencing of its receptors FZD4, 
FZD5, ROR1  and LRP6 and has shown a trend for 
reducing neuronal differentiation and gene 
expression. Instead, Slater et al., (2013) suggests a 
role for FZD5, in cell culture of hippocampal 
neurons of rat, in the establishment of neuronal 
polarity and in its morphogenesis, through the non-
canonical Wnt mechanism. 
Homology 
The FZD5 gene is conserved in chimpanzee, dog, 
cow, mouse, rat, chicken, zebrafish. The 
characteristic domain Fz, also known as CRD 
domain, is conserved in all the members of the 
Frizzled family 
Mutations 
Germinal 
Liu et al., (2016) reports an ultra-rare heterozygous 
frameshift mutation in FZD5 (p. Ala219Glufs*49) 
responsible of autosomal dominant non-syndromic 
coloboma. This frameshift variant is not a canonical 
substrate for nonsense-mediated decay, so the result 
is the production of a truncated protein, that lacks the 
transmembrane domain.  
The truncated protein is secreted from cells and 
becomes a dominant-negative FZD5 receptor, so it 
antagonises both canonical and non-canonical WNT 
signalling. 
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Somatic 
Wang et al., (2014) has observed 2 mutations in 
FZD5 that led to loss of functional pathway 
activation. The first one (p. Y46*) is a nonsense 
mutation that results in a premature truncation of the 
protein, generating a new protein (MT1) that led to a 
loss of Wnt-activating function. The second one (p. 
V290I) is a missense mutation that produces the 
protein named MT2. MT2, in contrast to MT1, did 
not change Wnt pathway activity. Some somatic 
mutations have been identified and described by 
COSMIC (Catalogue of Somatic Mutation In 
Cancer) and most are listed as nonsense, missense 
and synonymous substitutions; nevertheless, their 
role in disease has not yet been clarified. 
 
Figure 5:  Overview of major types of mutations occurring 
in FZD5. 
Implicated in 
Pancreatic ductal adenocarcinoma 
Pancreatic ductal adenocarcinoma (PDAC) is the 
most common malignancy of the pancreas. One of 
the most mutated gene in this type of cancer is 
RNF43, ubiquitin E3 ligase ring finger 43, suggested 
as a negative regulator of Wnt signalling. RNF43 
inhibits Wnt/β-catenin signalling by reducing 
Frizzled levels on the membranes (Jiang et al., 
2013). Considering this evident role of frizzled 
receptors in RNF43-mutant PDAC, has been 
discovered a unique requirement of Wnt/Fzd 
signalling: FZD5. As results, knockout of FZD5 led 
to robust growth inhibition in RNF43-mutant cells, 
and moreover they develop an anti-FZD5 antibody 
that inhibits the growth of RNF43-mutant PDAC 
through cell-cycle arrest. (Steinhart et al., 2017). 
Colorectal cancer 
One of the most common mutation in colorectal 
cancers (CRC) is RNF43, like PDAC. Like for 
PDAC, so for CRC using anti-FZD5 antibody has 
been proved that the FZD5 dependency may exist 
also in this type of cancer. As result, anti-FZD5 
antibody inhibits survival of RNF46-mutant CRC 
organoids. (Steinhart et al., 2017). 
Prostate cancer 
Prostate cancer (PCa) is the most common 
malignancy in men. Because WNT5A expression 
was significantly higher in PC3 cells, two common 
WNT5A receptors (FZD5 and ROR2) were 
investigated and as result, FZD5 was expressed 70-
fold higher in advanced PCa, while ROR2 was not 
significantly increased (Thiele et al., 2011). 
Gastric cancer 
FZD5 has a high overexpression in gastric cancer 
samples, due to the overexpression of its ligand, 
WNT5A, highly expressed in advanced stages of 
gastric cancer and correlated with poor prognosis 
(Bizama et al., 2014). 
Renal cell carcinoma 
FDZ5 is increased in RCC when compared to the 
normal kidney tissue, this can suggest a biomarker 
role in RCC. Moreover, its repression overcomes the 
chemo-resistance mediated by P-glycoprotein in 
RCC (Long et al., 2013). 
Type I endometrial carcinoma 
FZD5 is downregulated in type I endometrial 
adenocarcinoma, concordant with the 
downregulation of FZD5, and its ligand WNT5A, 
regulated by an estrogen receptor agonist and 
estradiol (Menezes Mde et al., 2011). Moreover, 
WNT7A also shows an upregulation correlated with 
a worse prognosis, by a signalling involving FZD5 
(Ford et al., 2015). 
Breast cancer 
Recently, has been suggested a role in the autocrine 
activation of Wnt signalling guided by the 
interaction between WNT10B and FZD5; this 
interaction has been proved in the breast cancer 
MCF7 cells, through PLA analysis (Lazzaroni et al., 
2016). 
Ovarian cancer 
A high number of malignant ovarian specimens are 
FZD5-positive than normal ovary. FZD5 is highly 
expressed in ovarian cancer cell lines, associated 
with poor prognosis, such as its ligand WNT5a, and 
it is upregulated by ARID3B (the DNA-binding 
protein AT-rich interactive domain 3B, a protein  
FZD5 (frizzled class receptor 5) Esposito I 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2019; 23(4) 84 
 
involved in chromatin remodelling and regulation of 
gene expression). This upregulation leads to 
increased adhesion to ECM components, such as 
fibronectin and collagen IV. Previously, it was 
demonstrated that FZD5 with its ligand WNT7A 
increases adhesion in ovarian cancer. As expected, 
knockdown of FZD5 in ovarian cancer cells leads to 
decreased adhesion (Bobbs et al., 2015). 
Coloboma 
Ocular coloboma is an eye malformation, resulting 
from incomplete fusion of the optic fissure during 
development. The classical description in medical 
literature is of a key-hole shaped defect in one or 
both the structures of the eye, in post-embryonic life. 
Coloboma is often associated with microphthalmia 
and/or contralateral anophthalmia, and together they 
represent the 10-15% of pediatric blindness. The 
Wnt receptor FZD5 mediates both canonical and 
non-canonical signalling in the development of the 
eye, depending on the organism. Recently, has been 
reported an ultra-rare frameshift mutation in FZD5, 
in zebrafish, that creates the A219Xfs*49 mutant 
transcript as result of a truncated FZD5 protein 
without the seven-transmembrane domain. This 
mutation converts FZD5 from a membrane-bound 
receptor to a secreted FZD antagonist that give 
dominant-negative effect to the WNT signalling. As 
result, retinal neuroblasts exhibit apical junction 
defects, leading to microphthalmia and coloboma. 
Liu et al., also shows that the effects on the eye were 
similar when both FZD5-wt and FZD5-mut were 
overexpressed, suggesting a key role of dosage in 
ocular development (Liu et al., 2016). 
Alcoholic liver disease 
Alcoholic liver disease (ALD) consists of a spectrum 
of disease that has the potentiality of progressing to 
hepatocellular carcinoma. Through microarray 
analysis has been found that FZD5 was the second 
key gene in the network of gene-modulating ALD. 
Its value in alcoholic hepatitis and cirrhosis was 
downregulated, leading to decreased gene activity 
and reduced synthesis of multi-transmembrane 
transport protein. This may reduce the binding 
between FZD5 and Wnt protein, as well as the 
number of β-catenin in the cytoplasm, leading to 
hepatocyte apoptosis (Liu et al., 2013). 
Amyotrophic lateral sclerosis 
FZD5 receptor is involved in the pathophysiology of 
ALS and in the response of neuronal cells against 
neurodegeneration. FZD5 shows changes in 
expression pattern during the progression of the 
disease, founding an increase immunoreactivity of 
this receptor (González-Fernández et al., 2016). 
Psoriasis Lesion 
WNT5a and FZD5 are mainly expressed in 
inflammatory and endothelial cells; moreover, they 
are expressed in healthy skin and overexpressed in 
psoriasis lesions (Zhang et al., 2015). 
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